Psychopharmacology and Psychiatry Updates
A podcast by Psychopharmacology Institute
Categorie:
213 Episodio
-
Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19
Pubblicato: 29/9/2021 -
How to Assess Psychotropic Drug Adherence
Pubblicato: 24/9/2021 -
Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)
Pubblicato: 19/9/2021 -
Delirium, Catatonia, and COVID-19
Pubblicato: 14/9/2021 -
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Pubblicato: 9/9/2021 -
Dopamine and Depression: Clinical Considerations
Pubblicato: 4/9/2021 -
Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium
Pubblicato: 30/8/2021 -
New Somatic Treatments for Child and Adolescent Depression
Pubblicato: 25/8/2021 -
Management of Delirium: Nonpharmacologic Strategies
Pubblicato: 20/8/2021 -
Emerging Complementary and Integrative Therapies for Geriatric Mental Health
Pubblicato: 15/8/2021 -
Delirium: Assessment, Consequences, and Sequelae
Pubblicato: 10/8/2021 -
In Search of a Dose-Response Relationship in SSRIs
Pubblicato: 5/8/2021 -
Valproate/Divalproex: Metabolism, Kinetics, and Warnings
Pubblicato: 31/7/2021
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.